These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 4476598)

  • 1. [Proceedings: Anomaly of calcium metabolism in the bone in hemodialysis patients. 3. Fluctuation of serum PTH levels].
    Imai T; Takatsuki K; Fujita T; Mitauma T; Nihei R
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):596. PubMed ID: 4476598
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study of bone metabolism in hemodialysis patients. I. Correlation with bone histology and serum levels of PTH, vitamin D metabolites, and vitamin A].
    Ohara K
    Nihon Jinzo Gakkai Shi; 1988 Apr; 30(4):417-36. PubMed ID: 3230693
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of decreasing serum calcium in serum during hemodialysis on PTH levels in children with end stage renal disease].
    Sieniawska M; Ziółkowska H; Pańczyk-Tomaszewska M; Weglarska J
    Pediatr Pol; 1995 Dec; 70(12):1017-22. PubMed ID: 8649940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
    Inaba M; Nagasue K; Okuno S; Ueda M; Kumeda Y; Imanishi Y; Shoji T; Ishimura E; Ohta T; Nakatani T; Kim M; Nishizawa Y
    Am J Kidney Dis; 2002 Jun; 39(6):1261-9. PubMed ID: 12046040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low calcium peritoneal dialysis solution. Effects on calcium metabolism and bone disease in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Pietrucci A
    ASAIO J; 1992; 38(3):M593-5. PubMed ID: 1457929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.
    Nakashima A; Yorioka N; Doi S; Masaki T; Ito T; Harada S
    Bone; 2004 Mar; 34(3):579-83. PubMed ID: 15003806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parathyroid hormone (PTH)].
    Sato K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():288-91. PubMed ID: 16149511
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of serum PTH (7-84) as a reliable nutritional marker in hemodialysis patients].
    Shidara K; Inaba M; Kumeda Y; Imanishi Y; Tahara H; Ishimura E; Nishizawa Y; Yamakawa T; Okuno S
    Clin Calcium; 2005 Sep; 15 Suppl 1():102-4; discussion 104-5. PubMed ID: 16279018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
    Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M
    Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments on plasma parathyroid hormone levels and their relationship to bone histopathology among patients undergoing dialysis.
    Goodman WG
    Semin Dial; 2007; 20(1):1-4. PubMed ID: 17244110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J; Piecha G; Kokot F; Wiecek A
    J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone and bone related biochemical examinations. Hormone and hormone related substances. Parathyroid hormone].
    Tanaka M; Fukagawa M
    Clin Calcium; 2006 Jun; 16(6):927-34. PubMed ID: 16751687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of 2 hours of moderate-intensity cycling on serum parathyroid hormone and calcium.
    Barry DW; Kohrt WM
    Calcif Tissue Int; 2007 Jun; 80(6):359-65. PubMed ID: 17549534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lowering dialysate calcium on bone and mineral parameters related to adynamic bone disease.
    Spasovski G; Vanholder R
    Ther Apher Dial; 2007 Dec; 11(6):455-6; author reply 457. PubMed ID: 18028174
    [No Abstract]   [Full Text] [Related]  

  • 20. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
    Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM
    J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.